Health & Medicine
The 23-Year Menopause Reversal: What 2026 Is Finally Getting Right About Hormone Therapy
After 23 years of caution rooted in a single 2002 trial, the FDA has finally pulled the black box warning from menopause hormone therapy. It is overdue, and lands on a public that barely knows the new story.
Health & MedicineThe 'Ozempic Babies' Phenomenon: Why GLP-1s Trigger Pregnancies
GLP-1 weight-loss drugs like Ozempic and Mounjaro are triggering an unexpected wave of 'Ozempic babies', often in women who had stopped expecting to ovulate. The drug is not a fertility treatment. The weight loss it produces is.
Health & MedicineThe Friendship Recession: Why Adults Have Fewer Close Friends
A fourfold rise in Americans with no close friends since 1990 is the headline. We dig into the data, the cultural forces, and the slow-friendship response.
Health & MedicinePFAS Forever Chemicals in Everyday Products: What Science Says in 2026
What PFAS forever chemicals are, where they hide in cookware, cosmetics and clothes, what the 2024 EPA drinking-water rule really does in 2026, and how to reduce exposure.
Health & MedicineSeed Oils vs Beef Tallow in 2026: The Linoleic Acid Science Verdict
Seed oils vs beef tallow is the food fight of 2026, pitting the new US 'Real Food' pyramid against Australian canola kitchens and a herd of boutique tallow brands.
Health & MedicineOzempic Face: Why GLP-1 Drugs and Rapid Weight Loss Change Your Face
Rapid weight loss on Ozempic deflates facial fat compartments, ages skin, and leaves hollows that fillers alone cannot fix. Here is the 2026 dermatology research on prevention, biostimulators, and what works.
Health & MedicineA Simple Blood Test for Alzheimer's: What the New pTau217 Test Means for Australian Patients
FDA-cleared pTau217 blood test matches PET scans for Alzheimer's — but Australia is still waiting. When will patients here actually get access?
Health & MedicineA Once-Daily Pill Doubles Survival in Pancreatic Cancer
In the RASolute 302 trial, daraxonrasib, a once-daily pill that targets active RAS, doubled median overall survival in previously treated metastatic pancreatic cancer.
Health & MedicineAustralia 2026 Flu Season: Super-K, Vaccines, and ATAGI Advice
Australia's 2026 Super-K flu season: what H3N2 Subclade K really means, the new trivalent vaccine, ATAGI advice, and how to tell flu from a cold or COVID.
Health & MedicineThe Adult ADHD Diagnosis Boom: Why So Many Women Are Finally Getting Answers in Their 30s and 40s
More women in their 30s and 40s are being diagnosed with ADHD than ever before. The surge is finally surfacing what clinicians missed for decades.
Health & MedicineHow Ozempic Is Quietly Becoming a Treatment for Alcohol Use Disorder
Semaglutide cut heavy drinking days by 41% in a 2026 Lancet trial of 108 people with alcohol use disorder. Here is the science and why doctors are prescribing it off-label.
Health & MedicineThe Physiological Sigh: The 30-Second Breathing Technique That Outperformed Meditation in a Stanford Trial
A 2023 Stanford trial found that the physiological sigh — a 30-second double inhale, slow exhale — beat beginner meditation for mood and breathing rate. Here's how it works.